Research progress of oral anticoagulants—cornerstone of atrial fibrillation treatment

VernacularTitle:心房颤动治疗的基石——口服抗凝药物的研究进展
Author: Yan-Li XU ¹ ; Yan-Feng TIAN ; Zhao-Guang LIANG
Author Information

1. 哈尔滨医科大学附属第一医院心内科,黑龙江哈尔滨 150001
Keywords: Atrial fibrillation; Anticoagulants; Therapy
From: Chinese Journal of cardiovascular Rehabilitation Medicine 2024;33(3):337-340
CountryChina
Language:Chinese
Abstract: Atrial fibrillation(AF)is one of the most common arrhythmias in clinical practice,accounting for about 1/3 of all hospitalized arrhythmic patients.With the increasing morbidity of AF and aggravation of aging of popula-tion,the number of AF patients will increase year by year.Long-term AF can cause a series of adverse clinical consequences such as stroke and heart failure,among which apoplexy is the most important cause of death and disa-bility of AF,while stroke is the most common manifestation of it.Therefore,the prevention of stroke in AF pa-tients through anticoagulation therapy has become the core strategy of AF treatment.In China,a considerable number of AF patients have not received effective anticoagulant therapy,which seriously affects the prognosis and normal life of AF patients.At present,there are many kinds of anticoagulant drugs.This article reviews the re-search progress of anticoagulant drugs.